Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.270
-0.210 (-4.69%)
At close: Jun 5, 2026, 4:00 PM EDT
4.258
-0.012 (-0.28%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $276.26 million as of June 5, 2026. Its market cap has increased by 418.71% in one year.
Market Cap
276.26M
Enterprise Value
81.34M
1-Year Change
418.71%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $276.26M, a decrease of -24.49%. That is a compound annual growth rate of -5.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 276.26M | -34.98% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 304.51M |
| Lineage Cell Therapeutics | 301.65M |
| Bicycle Therapeutics | 298.09M |
| InflaRx | 294.59M |
| Surrozen | 283.06M |
| Inhibikase Therapeutics | 282.90M |
| Armata Pharmaceuticals | 282.19M |
| Niagen Bioscience | 279.34M |